Butler John P.

CEO and President, DirectorAkebia Therapeutics, Inc. (AKBA) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$474K
Net Open-Market Flow
-$474K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Grant(A)175K$1.41$247K3.4M
Feb 2, 2026Sell(S)84K$1.39$116K3.3M
Feb 2, 2026Sell(S)115K$1.39$160K3.2M
Feb 2, 2026Sell(S)96K$1.39$134K3.3M
Feb 2, 2026Sell(S)47K$1.39$65K3.4M

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001591467-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: